Recent Market Performance and Price Movement
On 19 Dec 2025, National Peroxide’s share price touched an intraday low of Rs.471, representing a 3.22% dip during the trading session. The stock closed the day with a decline of 2.19%, underperforming the Sensex, which recorded a positive change of 0.53%. This movement followed two consecutive days of gains, signalling a reversal in short-term momentum.
The stock’s performance over various time frames highlights a persistent downward trend. Over the past week, National Peroxide’s shares have moved lower by 4.17%, compared to a 0.40% decline in the Sensex. The one-month period shows a sharper fall of 15.95%, while the three-month performance registers a 23.13% decline, contrasting with the Sensex’s 2.78% gain over the same period.
Year-to-date figures reveal a 40.50% reduction in the stock’s value, while the one-year performance shows a 45.14% decline. These figures stand in stark contrast to the Sensex’s respective gains of 8.69% and 7.21%. Over longer horizons, National Peroxide’s stock has not recorded appreciable gains in the last three, five, or ten years, remaining flat, whereas the Sensex has delivered substantial returns of 37.41%, 80.85%, and 232.80% respectively.
Technical Indicators and Moving Averages
Technical analysis reveals that National Peroxide is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning typically indicates sustained bearish sentiment and a lack of upward price momentum in the near to medium term.
The stock’s underperformance relative to its sector is also notable. On the day of the all-time low, it lagged the commodity chemicals sector by 4.25%, emphasising its weaker relative strength within its industry group.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Financial Metrics and Profitability Trends
National Peroxide’s financial data over recent years presents a challenging picture. The company’s operating profits have shown a compound annual growth rate (CAGR) of -135.58% over the last five years, indicating a significant contraction in core earnings capacity. This decline in operating profitability has contributed to the stock’s subdued valuation and market performance.
The company’s ability to service its debt is also constrained, with an average EBIT to interest ratio of 0.14. This ratio suggests that earnings before interest and tax are insufficient to comfortably cover interest expenses, raising concerns about financial leverage and sustainability.
Return on equity (ROE) averages at 1.90%, reflecting limited profitability generated from shareholders’ funds. Such a low ROE indicates that the company has struggled to deliver meaningful returns to its equity investors over time.
Recent Earnings and Income Composition
In the latest six-month period, National Peroxide reported a profit after tax (PAT) of Rs.1.28 crore, which represents a decline of 77.78% compared to the previous corresponding period. This subdued earnings performance aligns with the broader trend of weakening profitability.
Non-operating income has accounted for 263.49% of profit before tax (PBT) in the most recent quarter, indicating that a significant portion of the company’s earnings derives from sources outside its core operations. This reliance on non-operating income may reflect volatility in the company’s overall profit structure.
Valuation and Risk Considerations
The stock is currently trading at levels considered risky relative to its historical average valuations. Over the past year, while the stock’s price has declined by 45.14%, the company’s profits have contracted by 113%, underscoring the disconnect between market price and earnings performance.
National Peroxide’s underperformance extends beyond the short term. It has lagged the BSE500 index over the last three months, one year, and three years, highlighting persistent challenges in generating shareholder value relative to broader market indices.
Is National Peroxide your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Shareholding and Industry Context
National Peroxide operates within the commodity chemicals sector, a segment characterised by cyclical demand and sensitivity to raw material price fluctuations. The company’s majority shareholding is held by promoters, indicating concentrated ownership control.
Despite the sector’s overall dynamics, National Peroxide’s stock has not mirrored the broader market’s positive trajectory, as evidenced by its relative underperformance against the Sensex and BSE500 indices.
Summary of Current Situation
The stock’s fall to an all-time low of Rs.471 encapsulates a period of sustained financial and market challenges for National Peroxide. The combination of declining operating profits, constrained debt servicing capacity, low return on equity, and reliance on non-operating income has contributed to the subdued investor sentiment reflected in the share price.
Trading below all major moving averages and underperforming sector peers, the stock’s current valuation and price action highlight the difficulties faced by the company in regaining upward momentum within a competitive and volatile industry environment.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
